Al-Modawat Specialized Medical Co. carries a market capitalization of 120.22M, placing it among publicly traded companies globally. Its enterprise value stands at 221.64M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 120.22M |
| Enterprise Value | 221.64M |
Al-Modawat Specialized Medical Co. currently has 71.25M shares outstanding.
| Shares Outstanding | 71.25M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Al-Modawat Specialized Medical Co. trades at a trailing price-to-earnings ratio of 12.13.
| PE Ratio | 12.13 |
| PS Ratio | 1.90 |
| PB Ratio | N/A |
| P/TBV Ratio | 2.62 |
| P/FCF Ratio | 21.25 |
| P/OCF Ratio | 54.07 |
On an enterprise value basis, Al-Modawat Specialized Medical Co. trades at an EV/EBITDA multiple of 10.06 and an EV/FCF ratio of 17.05. The EV/Sales ratio of 1.82 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 10.06 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.82 |
| EV / EBITDA | 10.06 |
| EV / EBIT | 10.06 |
| EV / FCF | 17.05 |
Al-Modawat Specialized Medical Co. maintains a current ratio of 1.52, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.85, indicating elevated leverage, while an interest coverage ratio of 9.75 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.52 |
| Quick Ratio | 0.22 |
| Debt / Equity | 2.85 |
| Debt / EBITDA | 0.11 |
| Interest Coverage | 9.75 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 13.70 |
| Return on Invested Capital (ROIC) | 23.39 |
| Return on Capital Employed (ROCE) | 386.69 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, Al-Modawat Specialized Medical Co. has paid 1.31M in income taxes, reflecting an effective tax rate of 6.41.
| Income Tax | 1.31M |
| Effective Tax Rate | 6.41 |
Al-Modawat Specialized Medical Co.'s stock has declined approximately -11.84433% over the past 52 weeks. The 50-day moving average sits at 4.55, while the 200-day moving average is 4.86.
| Beta (5Y) | N/A |
| 52-Week Price Change | -11.84433% |
| 50-Day Moving Average | 4.55 |
| 200-Day Moving Average | 4.86 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Al-Modawat Specialized Medical Co. generated 121.82M in revenue and converted that into 19.07M in net income, yielding earnings per share of 0.39. EBITDA reached 22.04M, while operating income came in at 22.04M.
| Revenue | 121.82M |
| Gross Profit | 53.01M |
| Operating Income | 22.04M |
| Pretax Income | 20.37M |
| Net Income | 19.07M |
| EBITDA | 22.04M |
| EBIT | 22.04M |
| Earnings Per Share (EPS) | 0.39 |
Al-Modawat Specialized Medical Co. holds 12.12M in cash and equivalents against 2.52M in total debt, resulting in a net debt position of -12.12M.
| Cash & Cash Equivalents | 12.12M |
| Total Debt | 2.52M |
| Net Debt | -12.12M |
| Equity (Book Value) | N/A |
| Book Value Per Share | N/A |
| Working Capital | 28.55M |
Al-Modawat Specialized Medical Co. produced 4.28M in operating cash flow over the past twelve months. After subtracting -6.61M in capital expenditures, free cash flow totaled -2.33M - equivalent to -0.05 per share.
| Operating Cash Flow | 4.28M |
| Capital Expenditures | -6.61M |
| Free Cash Flow | -2.33M |
| FCF Per Share | -0.05 |
Al-Modawat Specialized Medical Co. operates with a gross margin of 43.52, reflecting its pricing power and cost economics. The operating margin of 18.09 and net profit margin of 15.65 provide insight into operational efficiency.
| Gross Margin | 43.52 |
| Operating Margin | 18.09 |
| Pretax Margin | 16.72 |
| Profit Margin | 15.65 |
| EBITDA Margin | 18.09 |
The company's payout ratio of 11.21 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.04 |
| Dividend Yield | N/A |
| Payout Ratio | 11.21 |
| Shareholder Yield | -5.83 |
| FCF Yield | 4.71 |
Al-Modawat Specialized Medical Co.'s most recent stock split took place on June 10, 2024 with a 1:10 split ratio.
| Last Split Date | 6/10/2024 |
| Split Ratio | 1:10 |
Al-Modawat Specialized Medical Co. posts an Altman Z-Score of 3.33, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.33 |